Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Hollandia
18 of 25 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- Where
- Breda, Enschede, Maastricht
- Életkor
- 40 év to 75 év
- People
- 1196 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00 - 2. fázisNot yet taking people in HollandiaA Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Where
- Almere, Apeldoorn, Eindhoven, Heerlen
- Életkor
- 40 év to 80 év
- People
- 402 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07725939 · EU 2026-525523-25-00 - 2. fázisVisszavonvaThe MAB Trial: A Study of Tozorakimab to Reduce Lung Inflammation and Promote Lung Healing in People with COPD.
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- University Of Leicester
See details and how to join2025-522359-24-00 - 3. fázisTaking peopleA Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- Where
- Leiden
- Életkor
- 18 év to 80 év
- People
- 40 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT07555483 · EU 2025-522792-29-00 - 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Where
- Arnhem, Breda, Dordrecht, Nijmegen, The Hague, Zutphen
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00 - 4. fázisTaking peopleA Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Where
- Groningen, Hoofddorp, Nijmegen, Rotterdam
- Életkor
- 40 év to 85 év
- People
- 218 worldwide
- Run by
- Sanofi
See details and how to joinNCT07053423 - No phaseTaking peopleBronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Where
- Groningen
- Életkor
- 40 év to 84 év
- People
- 250 worldwide
- Run by
- Apreo Health, Inc.
See details and how to joinNCT06891755 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Where
- Eindhoven, Maastricht, Rotterdam, Zutphen
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00 - 3. fázisTaking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- Where
- Breda, Deventer, Enschede, Haarlem, Harderwijk, Leeuwarden, Nijmegen, Zutphen, Zwolle
- Életkor
- 40 év to 80 év
- People
- 981 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00 - No phaseTaking peopleAn Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Where
- Groningen
- Életkor
- 40 év to 80 év
- People
- 200 worldwide
- Run by
- Pulmonx Corporation
See details and how to joinNCT06035120 - 4. fázisTaking peopleMolecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
- Where
- Groningen
- Életkor
- 40 év and over
- People
- 135 worldwide
- Run by
- Maria Joyera Rodríguez
See details and how to joinNCT06334575 - No phaseTaking peopleA Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema
- Where
- Groningen
- Életkor
- 22 év and over
- People
- 20 worldwide
- Run by
- Pulmair Medical, Inc.
See details and how to joinNCT07086339 - 2. fázisTaking peoplePsilocybin Therapy for Psychological Distress in Palliative Patients
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 108 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT06782724 · EU 2023-510488-36-01 - No phaseTaking peoplePEP-buddy in COPD: Effect on Dyspnea Severity and Mechanism of Action
- Where
- Groningen
- Életkor
- 40 év and over
- People
- 25
- Run by
- University Medical Center Groningen
See details and how to joinNCT05938738 - 4. fázisTaking peopleMolecular signatures associated with response to ICS treatment in patients with COPD stratified by eosinophil levels
- Where
- Groningen
- Életkor
- 18 év to 64 év
- People
- 60 worldwide
- Run by
- Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques August Pi I Sunyer
See details and how to join2023-505245-13-00 - No phaseTaking peopleTriple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease
- Where
- Rotterdam
- Életkor
- 40 év and over
- People
- 300
- Run by
- Franciscus Gasthuis
See details and how to joinNCT05495698 - No phaseTaking peopleHigh Flow Nasal Oxygen for Exacerbation COPD
- Where
- Delft, Rotterdam, The Hague
- Életkor
- 40 év and over
- People
- 40
- Run by
- Franciscus Gasthuis
See details and how to joinNCT06084117 - No phaseNot yet taking people in HollandiaThe REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema
- Where
- Groningen
- Életkor
- 40 év and over
- People
- 30 worldwide
- Run by
- Morair Medtech, LLC
See details and how to joinNCT06655428